ArticleEuropean respiratory review : an official journal of the European Respiratory Society2012
An integrated approach in the diagnosis of smoking-related interstitial lung diseases.
Article in European respiratory review : an official journal of the European Respiratory Society, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02665546 (Evaluation of Exercise Capacity and Mechanisms of Exercise Limitation in Patients With Pulmonary Langerhans Cell Histiocytosis), which is not on this map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Evaluation of Exercise Capacity and Mechanisms of Exercise Limitation in Patients With Pulmonary Langerhans Cell Histiocytosis
Who cites it
20 citing papers in PubMed, 53 citations in OpenAlex.
- Article
- Korean Guidelines for the Diagnosis and Management of Interstitial Lung Disease: Other Forms of Interstitial Lung Disease.Tuberculosis and respiratory diseases · 2025Article
- Immune-mediated lung diseases: A narrative review.Frontiers in medicine · 2023Review
- Fibrotic Idiopathic Interstitial Lung Disease: The Molecular and Cellular Key Players.International journal of molecular sciences · 2021Review
- Imaging patterns of early stage lung cancer for the thoracic surgeon.Journal of thoracic disease · 2020Review
- Desquamative interstitial pneumonia with clinical, radiological and histologic correlation.Radiology case reports · 2019Article
- TTC3 contributes to TGF-βCell death & disease · 2019Article
- The Gene Expression Biomarkers for Chronic Obstructive Pulmonary Disease and Interstitial Lung Disease.Frontiers in genetics · 2019Article
- Desquamative interstitial pneumonia: Risk factors, laboratory and bronchoalveolar lavage findings, radiological and histopathological examination, clinical features, treatment and prognosis.Experimental and therapeutic medicine · 2019Review
- Thorax Computed Tomography Findings in Patients with Erectile Dysfunction.Journal of clinical imaging science · 2017Article
- Action plans for COPD: strategies to manage exacerbations and improve outcomes.International journal of chronic obstructive pulmonary disease · 2016Review
- Are interstitial lung abnormalities associated with COPD? A nested case-control study.International journal of chronic obstructive pulmonary disease · 2016Article
- ATS Core Curriculum 2015. Part I: Adult Pulmonary Medicine.Annals of the American Thoracic Society · 2015Article
- Smoking and interstitial lung diseases.European respiratory review : an official journal of the European Respiratory Society · 2015Review
- Article
- Inflammatory lung disease in Rett syndrome.Mediators of inflammation · 2014Article
- [Interstitial lung diseases (ILD) in smokers: spectrum in high resolution computed tomography (HRCT)].Der Radiologe · 2013Article
- Smoking-related interstitial fibrosis (SRIF) and pulmonary hypertension.BMJ case reports · 2013Article
- Global effort against rare and orphan diseases.European respiratory review : an official journal of the European Respiratory Society · 2012Article
- Smoking-related interstitial lung disease: A narrative review.Chronic respiratory diseaseReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cigarette smoke consists of several chemical compounds with a variety of effects in many organs. In the lung, apart being the main cause of chronic obstructive pulmonary disease, carcinoma and idiopathic spontaneous pneumothorax, tobacco smoke is associated with interstitial lung diseases (ILDs), including respiratory bronchiolitis-associated ILD (RB-ILD), desquamative interstitial pneumonia (DIP), pulmonary Langerhans' cell histiocytosis (PLCH), idiopathic pulmonary fibrosis, acute eosinophilic pneumonia, ILD in rheumatoid arthritis and pulmonary haemorrhage in Goodpasture syndrome. This review will focus on the diseases with a stronger epidemiological association with tobacco smoke, namely RB-ILD, DIP and PLCH. Although the exact pathogenetic evidence linking smoking with these disorders is still not completely understood, there is growing evidence that tobacco smoke targets the terminal or respiratory bronchioles in these diseases, and the differences are reflective of the degree of severity of small airway and parenchymal reaction to the smoke exposure. Despite considerable clinical, radiological and histological overlap between RB-ILD, DIP and PLCH, it is useful to retain the separate classifications for prognostic and therapeutic implications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.